Please assess the completion status of the following clinical trial:

Trial Title: Erythropoietin in the Prevention of Acute Mountain Sickness

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy adults~Exclusion Criteria:~* History of serious illness~* Current smoker or Hemoglobin \>15.5gm/dL~* Uncontrolled hypertension

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Erythropoietin (Type: EXPERIMENTAL): Erythropoietin 10,000U, weekly, for 4 weeks Last dose: 1 week before departure (10days before high altitude)
- Control (Type: NO_INTERVENTION): No erythropoietin

Based on this trial design, predict the completion outcome and termination type (if applicable).